Conditions générales

PharmaTrust Terms of Service

Version 1.0. Effective 10 September 2026.
Approved by Dr. Qaria, Founder and Technical Director, NJMC Medical Supplies Co., Ltd, on 9 September 2026.
Previous versions are available on request from info@pharmatrust.tech (clause 15.3).

1. Agreement to these terms

These Terms of Service ("Terms") are a binding agreement between you and
NJMC Medical Supplies Co., Ltd. (南京米迪古卡亚尔医疗用品有限公司), a wholly
foreign-owned limited liability company registered in the People's
Republic of China under Unified Social Credit Code 91320100MAC61PPG8U,
with its registered address at Building B, Room 1417-49, No. 19 Junchen
Road, Jiangning District, Nanjing, Jiangsu Province, China
(南京市江宁区骏成路19号B座1417-49) ("PharmaTrust", "we", "us").

By creating an account, ticking the box marked "I agree to the Terms of
Service", or using the PharmaTrust platform in any way, you confirm that
you have read these Terms, that you accept them, and that you have
authority to accept them on behalf of the organisation you represent.

If you do not accept these Terms, do not create an account and do not use
the platform.

2. Definitions

Platform means the PharmaTrust web application, its application
programming interface, and any reports or outputs it produces.

Customer Content means any document, data or file you upload to the
platform, including Certificates of Analysis, Certificates of Suitability
and Good Manufacturing Practice certificates.

Report means the output the platform produces after processing a
document you submit: an Automated Analysis, or an Expert-Reviewed
Analysis where a qualified reviewer has issued one.

Monograph Data means the structured limit values, test names, method
references and monograph citations held in our database and derived from
pharmacopoeial sources under licence.

Access period means the fixed period of paid access you have bought
(one month, one year or two years), at the tier you selected, with the
document allowance stated for that tier.

3. What PharmaTrust is, and what it is not

This section is the most important part of these Terms. Read it carefully.

3.1 PharmaTrust is decision-support software. It compares values
reported on a submitted Certificate of Analysis against structured limit
data derived from licensed pharmacopoeial monographs, and it returns a
report together with the monograph reference it applied.

3.2 PharmaTrust does not reproduce pharmacopoeial monographs and is not
a substitute for them. The applicable pharmacopoeia remains the sole
authoritative standard for the quality of any pharmaceutical substance or
product.

3.3 PharmaTrust does not perform any laboratory testing. It reads and
evaluates the document you give it. It has no way of knowing whether the
values printed on that document are true, whether the testing described
was actually carried out, or whether the material in your possession
corresponds to the batch named on the certificate.

3.4 A report finding that a value passes means only that the values
reported on the submitted document fall within the limits held in our
database for the monograph identified. It is not a certification of
quality, a batch release decision, a confirmation of authenticity, or a
statement that the material is safe or fit for its intended use. PharmaTrust
does not certify or verify compliance and does not act as a pharmacopoeia.

3.5 Batch release remains the responsibility of a Qualified Person or
the equivalent role under the regulations applicable to you. Nothing
produced by the platform transfers, reduces or discharges that
responsibility.

3.6 Where a report identifies a failure, a missing value, an alignment
gap or an item requiring review, you should not accept, release or
distribute the material without referring the matter to a qualified person
or submitting a sample to an accredited testing laboratory.

3.7 The platform is not a medical device, and it does not make
clinical, diagnostic or therapeutic determinations.

4. Eligibility and accounts

4.1 You must be at least 18 years old and legally able to enter into
contracts to use the platform.

4.2 You are responsible for the accuracy of the registration
information you provide and for keeping it current.

4.3 You are responsible for all activity that occurs under your
account and for keeping your login credentials confidential. Tell us
immediately at info@pharmatrust.tech if you believe your
account has been accessed without your authority.

4.4 Accounts are issued to a named individual within a named
organisation. You may not share credentials with any other person. Where
your tier includes multiple users, each user must have their own
account.

5. Access periods, fees and payment

5.1 The features, document allowance and price of each tier, the
allowance of free accounts, and the allowance of the public-health access
programme for eligible institutions are set out at
https://pharmatrust.tech/pricing and https://pharmatrust.tech/access-programme.

5.2 Paid access is bought outright, in advance, for the access period
you choose. Fees are stated exclusive of any taxes, duties or bank charges,
which are your responsibility. Access to a paid period begins when payment
is confirmed.

5.3 Nothing renews automatically. We hold no standing authority over
your payment method. Your access ends at the end of the period you paid
for unless you buy a further period; we send a reminder before it ends.
Any introductory discount applies to a first purchase only; later
purchases are at the standard price unless a promotion says otherwise.

5.4 Except where required by law, fees already paid are not
refundable. If we materially reduce the core functionality of a paid tier
during a period you have already paid for, you may end this agreement and
request a pro rata refund for the unused portion.

5.5 If a payment is reversed or charged back after access has been
granted, we may suspend the paid access it bought after giving you written
notice and a reasonable period to correct the problem.

5.6 We may change our prices. A change never affects a period you
have already paid for.

6. Acceptable use

You agree not to:

6.1 Upload any document you do not have the right to upload, or any
document containing personal data beyond what is normally present on a
certificate of analysis.

6.2 Use the platform to produce, alter or assist in the production of
a false, misleading or falsified certificate.

6.3 Represent a report as a certification, an accreditation, a
regulatory approval, or a laboratory test result.

6.4 Alter a report, or present part of one in a way that changes its
meaning, including removing the disclaimers it carries.

6.5 Attempt to extract, copy, scrape or reconstruct the Monograph Data,
in whole or in part, by any means, including automated querying of the
platform or its API, or the submission of documents constructed for the
purpose of eliciting limit values rather than analysing a genuine
certificate.

6.6 Reverse engineer, decompile or attempt to derive the source code
or the rule logic of the platform.

6.7 Resell, sublicense or provide access to the platform to any third
party, except under a written reseller or partner agreement with us.

6.8 Use the platform in any way that breaches applicable law,
including export control and sanctions regulations, or that would cause
us to breach such law.

6.9 Interfere with the operation or security of the platform, or
attempt to gain access to data belonging to another customer.

7. Customer Content

7.1 You retain all rights in your Customer Content. Uploading a
document to the platform does not transfer ownership of it to us.

7.2 You grant us a limited licence to store, process, transmit and
analyse your Customer Content solely to provide the platform to you, to
generate your reports, and to maintain the audit records these Terms and
applicable regulations require.

7.3 You confirm that you have the right to upload each document you
submit, and that doing so does not breach any confidentiality obligation
you owe to your supplier or to any other party.

7.4 We treat Customer Content as confidential. We do not sell it, and
we do not disclose it to other customers. Our handling of it is described
in the Privacy Notice.

7.5 Any use of Customer Content to improve the accuracy of the
platform is governed by the Privacy Notice and, where applicable, the
separate Data Processing Addendum. Where such use requires your consent,
we will not proceed without it.

8. Intellectual property

8.1 The platform, its software, its rule engine, its user interface,
the PharmaTrust name and logo, and the structure and content of the
Monograph Data are owned by us or licensed to us. Nothing in these Terms
transfers any of those rights to you.

8.2 Pharmacopoeial monographs are the copyrighted works of their
respective publishing authorities, which remain the sole authoritative
source. The sources applied, with their versions, are named in every report
and on https://pharmatrust.tech/trust, together with any attribution or
notice a licensor requires. The Monograph Data is applied only in the
analysis of a document you submit: the only values shown to you are those
applied to the tests reported on that document, each with its citation and
a link to the publishing authority's source. The platform provides no
function to browse, search, list, export or download the Monograph Data,
and its API returns only the analysis of a document you have submitted.
Your access period does not grant you a licence to any pharmacopoeia.

8.3 Reports produced for you are yours to use within your own
organisation and to share with your suppliers, customers and regulators,
provided you share them complete and unaltered.

8.4 If you send us feedback or suggestions, we may use them without
restriction and without obligation to you.

9. Availability and support

9.1 We aim to keep the platform available at all times but we do not
guarantee uninterrupted availability except where a written service level
agreement applies to your tier.

9.2 We may carry out scheduled maintenance. Where maintenance is
likely to interrupt service we will give reasonable advance notice.

9.3 Support channels and response targets for each tier are set out
at https://pharmatrust.tech/contact.

10. Confidentiality

10.1 Each party may receive confidential information from the other.
Each party will protect the other's confidential information with at
least the care it applies to its own, and will use it only for the
purposes of this agreement.

10.2 This obligation does not apply to information that is or becomes
public through no fault of the receiving party, was already lawfully
held, is independently developed, or must be disclosed by law or court
order.

10.3 These obligations continue for three years after your account is
closed.

11. Warranties and disclaimers

11.1 We warrant that we will provide the platform with reasonable
skill and care, and that we hold the licences necessary for the
Monograph Data we make available.

11.2 Except as stated in clause 11.1, and to the fullest extent
permitted by law, the platform is provided on an "as is" and
"as available" basis. We do not warrant that the platform will be error
free, that extraction from any document will be complete or accurate,
that any monograph match will be correct, or that any result will meet
your requirements or those of any regulator.

11.3 Optical character recognition and automated data extraction are
imperfect. Document quality, layout, language and scanning artefacts all
affect accuracy. You are responsible for reviewing the extracted values
shown in each report against the source document before relying on the
result.

11.4 Monographs are revised by their publishing authorities. We update
the Monograph Data on a regular cycle, but a monograph may be revised
between our updates. Each report records the monograph version applied.

12. Limitation of liability

12.1 Nothing in these Terms limits liability for death or personal
injury caused by negligence, for fraud or fraudulent misrepresentation, or
for any other liability that cannot be limited under applicable law.

12.2 Subject to clause 12.1, neither party is liable to the other for
loss of profit, loss of revenue, loss of anticipated savings, loss of
business opportunity, loss of goodwill, or any indirect or consequential
loss.

12.3 Subject to clause 12.1, our total liability arising out of or in
connection with these Terms, whether in contract, tort, breach of
statutory duty or otherwise, is limited in aggregate to the total fees you
paid to us in the twelve months immediately preceding the event giving
rise to the claim.

12.4 We are not liable for any decision you take to accept, reject,
release, purchase or distribute any pharmaceutical material, nor for any
regulatory action, recall, product liability claim or harm arising from
such a decision. Those decisions are yours, and clause 3 sets out the
limits of what the platform can tell you.

13. Indemnity

You will indemnify us against any claim, loss or expense arising from your
breach of clause 6 (Acceptable use), from your lack of right to upload any
Customer Content, or from your presentation of a report as something
other than what clause 3 describes.

14. Suspension and termination

14.1 Nothing renews, so there is nothing to cancel: your paid access
simply ends at the end of the period you paid for. You may close your
account at any time through your account settings or by writing to
info@pharmatrust.tech.

14.2 We may suspend your access immediately where we reasonably
believe you are in breach of clause 6, where required by law, or where
continued access presents a security risk. We will tell you why, and we
will restore access if the cause is resolved.

14.3 Either party may terminate this agreement on 30 days' written
notice, or immediately if the other party commits a material breach that
is not remedied within 14 days of written notice.

14.4 After termination we retain your Customer Content and reports for
the periods stated in the Retention & Deletion Policy, so that your audit
trail remains intact. You may export your reports at any time before
termination, and for 30 days afterwards.

14.5 Clauses 7.1, 8, 10, 11, 12, 13 and 16 survive termination.

15. Changes to the platform and to these Terms

15.1 We may change or improve the platform. We will not materially
reduce the core functionality of a tier you have paid for during a period
you have already paid for.

15.2 We may amend these Terms. Where an amendment is material we will
give at least 30 days' notice by email and through the platform, and we
will ask you to accept the new version at your next login. Continuing to
use the platform after the effective date of an amended version means you
accept it.

15.3 Every version of these Terms is numbered and dated. Previous
versions are available on request from info@pharmatrust.tech.

16. Governing law and disputes

16.1 These Terms are governed by the laws of the People's Republic of
China.

16.2 The parties will first attempt to resolve any dispute by good
faith discussion between senior representatives, within 30 days of
written notice of the dispute.

16.3 If the dispute is not resolved, it will be submitted to the
people's court with jurisdiction over our registered address in Nanjing,
Jiangsu Province, China. The English text of these Terms governs, and any
translation is for convenience only.

16.4 Nothing in this clause prevents either party from seeking urgent
injunctive relief from a competent court.

17. General

17.1 These Terms, together with the Privacy Notice and any order form
or written agreement signed between us, form the entire agreement between
the parties.

17.2 If any provision is held invalid, the rest remains in force.

17.3 A failure to enforce any provision is not a waiver of it.

17.4 You may not assign this agreement without our written consent.
We may assign it to a successor in connection with a merger, acquisition
or sale of assets.

18. Contact

Questions about these Terms: info@pharmatrust.tech
Company: NJMC Medical Supplies Co., Ltd. (南京米迪古卡亚尔医疗用品有限公司),
Building B, Room 1417-49, No. 19 Junchen Road, Jiangning District,
Nanjing, Jiangsu Province, China (南京市江宁区骏成路19号B座1417-49)